Trial intelligence / Profile preview

Urotherapy vs Urotherapy + Constipation Treatment for MNE

NCT02337413Phase 4Withdrawn

Sponsor
Rabin Medical Center
Start
Jun 2020
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of senna + docusate in nocturnal enuresis (NE), sponsored by Rabin Medical Center. Planned start Jun 2020; status: withdrawn.

02

Drugs

senna + docusate
03

Conditions

nocturnal enuresis (NE)

Beyond the preview

Go deeper on NCT02337413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02337413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call